Description

Inosita Plus is used to manage type II diabetes mellitus. It contains Sitagliptin (50mg) and Metformin (850mg). Sitagliptin increases insulin production and decreases glucose production, while Metformin helps regulate blood sugar levels. This combination classifies as a DPP-4 inhibitor and antihyperglycemic agent. The recommended duration of use should be as advised by a healthcare professional.